Filter Results:
(2,544)
Show Results For
- All HBS Web
(5,362)
- People (16)
- News (1,978)
- Research (2,544)
- Events (3)
- Multimedia (222)
- Faculty Publications (1,904)
Show Results For
- All HBS Web
(5,362)
- People (16)
- News (1,978)
- Research (2,544)
- Events (3)
- Multimedia (222)
- Faculty Publications (1,904)
Sort by
- August 2008 (Revised May 2009)
- Background Note
Note on Generic Drugs in the European Union
By: Robert C. Pozen and Elizabeth M. Leonard
Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S. View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States
Pozen, Robert C., and Elizabeth M. Leonard. "Note on Generic Drugs in the European Union." Harvard Business School Background Note 309-019, August 2008. (Revised May 2009.)
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- 11 Jan 2000
- Research & Ideas
Calling All Managers: How to Build a Better Call Center
delivery had almost entirely been overlooked. Before being able to generate revenue through the call center, institutions have to fully understand and be able to implement superior customer service." "Each service interaction forms the basis of a consumer's... View Details
- 01 Aug 2008
- Research & Ideas
Does Market Capitalism Have a Future?
warfare, and crime; and global health issues, including pandemics. Finally, our participants cited the inability of existing global institutions—whether by poor design or lack of international support—to address these challenges. We... View Details
Keywords: by Garry Emmons
- 05 Nov 2021
- Op-Ed
How to Tap the Talent Automated HR Platforms Miss
As the global staffing shortage grinds on, corporate recruiters everywhere are relying on their online hiring platforms and automated systems to deliver the candidates they need. Too often, these tools will fail them, sidelining many qualified workers in the process.... View Details
Keywords: by Joseph B. Fuller
- 25 Jul 2005
- Research & Ideas
An Organization Your Customers Understand
the role of organization in regard to a business unit's success, or in the choice of which structure to use, is intertwined with a large number of other important factors. These include the strategy of the business, the quality of its... View Details
Keywords: by Robert Simons
- 15 Oct 2013
- First Look
First Look: October 15
governments holding a non-permanent seat on the United Nations Security Council or an Executive Directorship at the World Bank-are no more likely, on average, to get a negative quality rating than other projects. When aid is given to... View Details
Keywords: Sean Silverthorne
- 05 Sep 2006
- Research & Ideas
HBS Cases: Porsche’s Risky Roll on an SUV
Products German craftsmanship and quality are famous, and according to Fear, German companies generally compete as niche producers, particularly those that manufacture high-quality goods that demand a premium price. In 2004-2005 Germany... View Details
- 05 Apr 2004
- What Do You Think?
Should We Brace Ourselves for Another Era of M&A Value Destruction?
approach an acquisition like a conquering hoard, focusing on the numbers while remaining insensitive to the qualities and needs of the human resources being acquired. Carey and Ogden set out to examine the methods for integrating an... View Details
Keywords: by James Heskett
- September 2021 (Revised October 2022)
- Supplement
Hester Pharmaceuticals (B): Securing Supply
By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was... View Details
Keywords: COVID-19 Pandemic; Cost vs Benefits; Trade; Supply Chain; Global Strategy; Buildings and Facilities; Operations; Health Care and Treatment; Demand and Consumers; Global Range; Globalized Markets and Industries; Pharmaceutical Industry; Italy; China; United States; Germany
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (B): Securing Supply." Harvard Business School Supplement 722-009, September 2021. (Revised October 2022.)
- January 2021 (Revised June 2021)
- Case
Hester Pharmaceuticals (A): A Pricing Dilemma
By: Dante Roscini and John Masko
In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details
Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (A): A Pricing Dilemma." Harvard Business School Case 721-001, January 2021. (Revised June 2021.)
- July 2000 (Revised November 2001)
- Case
Catalyst Medical Solutions
By: Amy C. Edmondson, Richard M.J. Bohmer and Naomi Atkins
Faced with a drop in the NASDAQ, four eHealth entrepreneurs must decide between two distribution strategies for their new company's technology. The team, comprised of three full-time resident physicians and an MBA, has developed software to enable electronic... View Details
Keywords: Product Development; Health Care and Treatment; Distribution; Strategy; Venture Capital; Applications and Software; Partners and Partnerships; Borrowing and Debt; Information Technology Industry; Service Industry
Edmondson, Amy C., Richard M.J. Bohmer, and Naomi Atkins. "Catalyst Medical Solutions." Harvard Business School Case 601-014, July 2000. (Revised November 2001.)
- December 2007 (Revised July 2009)
- Case
Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?
GI has developed a revolutionary video pill for imaging the small bowel in the gastro-intestinal tract. The development has required the integration of wide variety of technologies. GI founder and CEO Gabriel Meron must determine GI's marketing strategy and prioritize... View Details
Keywords: Medical Specialties; Globalized Markets and Industries; Decisions; Technological Innovation; Marketing Strategy; Market Entry and Exit; Entrepreneurship; Health Care and Treatment; Corporate Finance; Medical Devices and Supplies Industry; Japan; United States; Europe
Isenberg, Daniel J. "Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?" Harvard Business School Case 808-033, December 2007. (Revised July 2009.)
- 03 Jan 2017
- Research & Ideas
5 New Year's Resolutions You Can Keep (With the Help of Behavioral Science Research)
suggest that the mere provision of information on peer health behaviors can have perverse effects on one's health behavior." To learn more, see Converging to the Lowest Common Denominator in Physical View Details
Keywords: by Carmen Nobel
- 25 Jan 2011
- First Look
First Look: Jan. 25
Living Kidney Donation Authors:Ruthanne L. Hanto, Alvin E. Roth, M. Utku Ünver, and Francis L. Delmonico Publication:Chap. 8 in Kidney Transplantation: A Guide to the Care of Transplant Recipients, edited by D. McKay and S. Steinberg,... View Details
Keywords: Sean Silverthorne
- 05 Mar 2019
- First Look
New Research and Ideas, March 5, 2019
lack prior ties to others at the bootcamp experience peer effects that influence the quality of their product prototypes. A one-standard-deviation increase in the performance of proximate teams is related to a two-thirds... View Details
Keywords: Dina Gerdeman
- 09 Dec 2014
- First Look
First Look: December 9
The survey showed, for instance, that 1) the highly educated, ambitious women and men of HBS don't differ much in terms of what they value and hope for in their lives and careers; 2) it simply isn't true that a large proportion of HBS alumnae have "opted out"... View Details
Keywords: Sean Silverthorne
- 17 Feb 2016
- Research & Ideas
Man vs. Machine: Which Makes Better Hires?
who has studied how companies make organizational decisions in industries such as health care and education. “They are figuring out how to use the information of managers and combine it with this new... View Details
- August 2023
- Case
Augmenix: Space to Think Differently
By: Satish Tadikonda and Sidhant Jena
Amar Sawhney, a serial medtech entrepreneur, had founded Augmenix to develop and commercialize a hydrogel-based medical device called SpaceOAR as an adjunctive technology to core radiation therapy. This technology was used to protect organs at risk (OAR) during... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Technology Adoption; Innovation Strategy; Technological Innovation; Product Development; Commercialization; Medical Devices and Supplies Industry
Tadikonda, Satish, and Sidhant Jena. "Augmenix: Space to Think Differently." Harvard Business School Case 824-031, August 2023.